OXiGENE (OXGN) Reports Full Year 2013 Financial Results
3/19/2014 9:30:36 AM
SOUTH SAN FRANCISCO, Calif., March 18, 2014 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN), a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer, reported financial results for the year ended December 31, 2013.
Help employers find you! Check out all the jobs and post your resume.